Effect of a Probiotic Strain Lactobacillus Paracasei K56 on Metabolic Symptom - a Pilot Study

NCT04980599 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 118

Last updated 2023-01-10

No results posted yet for this study

Summary

Recent data suggest that gut microbiota can function as an environmental factor that modulates the amount of body fat and obese individuals have an altered gut microbiota.The results of previous animal studies have suggest that a probiotic strain Lactobacillus paracasei K56 have reduced high-fat diet induced obesity.

In this before-after pilot study, the participants were randomly assigned to 8 groups to compare the fat-reducing effect of the Lactobacillus paracasei K56 by continuously supplementing different product prototypes , and screen the best probiotic K56 prototype with the effect of fat reduction.

Conditions

Interventions

DIETARY_SUPPLEMENT

probiotic drink with Lactobacillus paracasei K56

Probiotic drink (K56 10\^11CFU) 350ml/d for 60days

DIETARY_SUPPLEMENT

maltodextrin

maltodextrin ,for 60days

DIETARY_SUPPLEMENT

Probiotic powder E3

Probiotic powder 3.0g/d (K56 10\^10cfu) 60days;

DIETARY_SUPPLEMENT

Probiotic powder E5

probiotic powder 8g/day for 60days

DIETARY_SUPPLEMENT

probiotic capsule E7

probiotic k56 capsule, 2capsules/d (10\^7cfu) for 60days

DIETARY_SUPPLEMENT

probiotic capsule E9

probiotic k56 capsule, 2capsules/d (10\^9cfu) for 60days

DIETARY_SUPPLEMENT

probiotic capsule E10

probiotic k56 capsule, 2capsules/d (10\^10cfu) for 60days

DIETARY_SUPPLEMENT

probiotic capsule E11

probiotic k56 capsule, 4capsules/d (10\^11cfu) for 60days

Sponsors & Collaborators

  • Inner Mongolia Yili Industrial Group Co., Ltd

    collaborator INDUSTRY
  • Fudan University

    lead OTHER

Principal Investigators

  • Ying Feng, Ph.D · Hua Dong Hospita Affiliated to Fu Dan University, Shanghai,China

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-10
Primary Completion
2021-08-30
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04980599 on ClinicalTrials.gov